Announcement of Offer Price

Hansard Global plc
13 December 2006


This announcement and the information contained herein is not for publication,
distribution or release, in whole or in part, in, or into, directly or
indirectly, the United States, Australia, Canada and Japan or any other
jurisdiction where such publication, distribution or release would be unlawful.

This announcement is an advertisement and not a prospectus. Investors should not
purchase or subscribe for any shares referred to in this announcement except on
the basis of information in the prospectus (the 'Prospectus') which is expected
to be published in due course by Hansard Global plc ('Hansard' or the 'Company'
and, together with its subsidiaries, the 'Group') in connection with Admission
(as defined below) and the proposed offer of ordinary shares in the capital of
the Company (the 'Shares') to institutional investors and management (the
'Offer'). Copies of the Prospectus will be available after its publication in
accordance with the Prospectus Rules of the Financial Services Authority from
Hansard Global plc's registered office at Harbour Court, Lord Street, Douglas,
Isle of Man, IM99 1QL, from the office of Lazard & Co., Limited at 50 Stratton
Street, London W1J 8LL and from the office of Panmure Gordon (UK) Limited at 155
Moorgate, London EC2M 6XB.


13 December 2006

                               HANSARD GLOBAL PLC

                          Announcement of Offer Price

                             of 260 pence per Share

Hansard Global plc, the specialist long-term savings provider, today announces
the price for the Offer of its Shares (the 'Offer Price'). Following strong
interest in the Offer from institutional investors, Hansard is pleased to
announce that the Offer Price has been set at 260 p per Share.

Highlights

   • Offer Price of 260 p per Share.

   • Based on the Offer Price, the market capitalisation of Hansard at the
     commencement of conditional dealings will be approximately £357 million.

   • The Offer comprises 50,671,326 Shares, representing approximately 37% of
     the Company's issued ordinary share capital, implying an Offer size of £132
     million.

   • In addition, Polar Cap Limited (the 'Selling Shareholder') has granted
     Panmure Gordon (UK) Limited ('Panmure Gordon') an over-allotment option of
     up to 7,600,699 Shares, representing approximately 15% of the Shares
     comprised in the Offer, exercisable for a period of up to 30 days from
     today.

   • No new Shares are being offered by the Company in connection with the
     Offer and no proceeds from the Offer will therefore be received by the
     Company.

   • The Shares are being offered to a broad base of institutional investors
     in the UK and internationally.

   • Conditional dealings are expected to commence on the main market for
     listed securities of the London Stock Exchange at 8.00 a.m. today under the
     ticker symbol HSD. Any dealings in Shares before the commencement of
     unconditional dealings will be on a 'when issued' basis, at the sole risk 
     of the parties concerned and of no effect if Admission does not take place.

   • The admission of the Shares to the Official List of the Financial
     Services Authority and commencement of unconditional dealings on the main
     market for listed securities of the London Stock Exchange plc (together,
     'Admission') is expected to take place at 8.00 a.m. on 18 December 2006.

   • Lazard & Co., Limited ('Lazard') is acting as Financial Adviser to the
     Selling Shareholder and Dr Leonard Polonsky and Sponsor to the Company in
     connection with the Offer.

   • Panmure Gordon is acting as Bookrunner to the Offer. Fox-Pitt, Kelton N.V. 
     is acting as Co-Lead Manager to the Offer.

Commenting on today's announcement, Dr Leonard Polonsky, Executive Chairman,
Hansard Global plc, said:

'The Offer Price reflects the very positive response of investors to the
flotation of Hansard, marking the beginning of the next chapter in the
development of the Group. This will help us achieve our strategy to raise our
profile with financial intermediaries which we believe will assist us in
attracting new business.  Hansard is well-positioned to benefit from the
projected growth of the global wealth management market and we aim to generate
sustainable growth in value for all our shareholders.'

                                    - ends -

For further information

Hansard                                                01624 688 000
Dr. Leonard Polonsky, Executive Chairman
Gordon Marr, Director and Group Counsel


Lazard                                                 020 7187 2000
Jon Hack
Stuart Mackay
Nick Millar


Panmure Gordon                                         020 7459 3600
Tim Linacre
Aubrey Powell
Gilbert Ellacombe
Giles Stewart

Bell Pottinger                                         020 7861 3232
Stephen Benzikie
Ben Woodford
Daniel de Belder


Summary Information on Hansard

   • The Group is a specialist long-term savings provider, based on the Isle
     of Man.

   • The Group offers a range of flexible and tax-efficient investment
     products within a life assurance policy wrapper, designed to appeal to
     affluent, international investors.

   • The Group has designed its products and distribution methods with a view
     to reducing operational and financial risks.

   • The Group sells policies exclusively through a network of over 470
     financial services intermediaries, independent financial advisers and the
     retail operations of certain financial institutions, who provide access to
     their clients in more than 170 countries.

   • The Group's low-cost distribution model is scaleable and supported by
     Hansard OnLine, its award-winning, multi-language internet platform.

   • The Directors believe that the Group has excellent growth prospects,
     operating within the global wealth management market, which it is estimated
     will grow in aggregate by 6 per cent per annum between 2005 and 2010.

   • The Group is well capitalised and has a track record of profitable
     growth.

   • The Group has an experienced and long serving management team.


Important Information

No offer or invitation to purchase or subscribe for securities of the Company is
being made at this time. Any such offer or invitation will be made solely in or
by reference to the Prospectus which is expected to be published in due course
and any acquisition of securities of the Company should be made only on the
basis of the information contained in the Prospectus and any supplement or
amendment thereto.

The contents of this announcement, which have been prepared by and are the sole
responsibility of the Company, have been approved by Lazard solely for the
purposes of section 21(2)(b) of the Financial Services and Markets Act 2000.
Lazard, Panmure Gordon and Fox-Pitt, Kelton Ltd. are regulated in the United
Kingdom by the Financial Services Authority and Lazard, Panmure Gordon and
Fox-Pitt, Kelton Ltd, are acting for the Company and the Selling Shareholder and
no-one else, and Lazard and Panmure Gordon are acting for Dr. Leonard Polonsky,
and Fox-Pitt, Kelton Ltd. is acting for the Company and the Selling Shareholder,
and no one else in connection with the Offer and Admission and will not regard
any other person (whether or not a recipient of this announcement) as their
respective clients, nor will they be responsible to anyone other than the
Company, the Selling Shareholder or Dr. Leonard Polonsky for providing the
protections afforded to the respective clients of Lazard and Panmure Gordon and
Fox-Pitt, Kelton Ltd, nor for providing advice in relation to the Offer, the
contents of this announcement or any transaction, arrangement or other matter
referred to herein.

This announcement does not constitute an offer to sell or the solicitation of an
offer to buy securities of the Company in any jurisdiction in which such offer,
solicitation or sale would be unlawful prior to registration, exemption from
registration or qualification under the securities law of any such jurisdiction.

The Offer is being made in the United Kingdom and elsewhere outside the United
States by means of an Offer to institutional investors. This announcement and
the information contained herein is not for publication, distribution or release
in, or into, directly or indirectly, the United States, Australia, Canada or
Japan and does not constitute, or form part of, an offer of the securities for
sale in or into the United States, Australia, Canada or Japan. The Offer and the
distribution of this announcement may be restricted by law in certain
jurisdictions and persons into whose possession any document or other
information referred to herein comes should inform themselves about and observe
any such restriction. Any failure to comply with these restrictions may
constitute a violation of the securities laws of any such jurisdiction.

The securities referred to in this document have not been registered under the
U.S. Securities Act of 1933, as amended (the 'Securities Act') and may not be
offered or sold in the United States absent registration or an exemption from
the registration requirements of the Securities Act. The Company does not
presently intend to offer publicly any securities in the United States or to
register any securities under the Securities Act.

This announcement does not constitute a recommendation concerning the Offer. The
value of shares can go down as well as up. Potential investors should consult a
professional advisor as to the suitability of the Offer for the individual
concerned.


Forward looking statements

The contents of this announcement include statements that are, or may be deemed
to be 'forward looking statements'. These forward-looking statements can be
identified by the use of forward-looking terminology, including, without
limitation, the terms 'believes', 'estimates', 'anticipates', 'expects',
'intends', 'may', 'will' or 'should'. By their nature, forward looking
statements involve risks and uncertainties and readers are cautioned that any
such forward-looking statements are not guarantees of future performance. A
number of factors could cause the Company's actual results and performance to
differ materially from the impression created by the forward-looking statements
including, without limitation, the factors to be described in the risk factors
section of the Prospectus. Save as required by law or by the Listing Rules of
the Financial Services Authority, the Company undertakes no obligation to
publicly update or revise forward-looking statements, except as may be required
by applicable law and regulation (including the Listing Rules). No statement in
this announcement is intended to be a profit forecast or be relied upon as a
guide to future performance.


Stabilisation

In connection with the Offer, Panmure Gordon (the 'Stabilising Manager'), or any
of its agents, may (but will be under no obligation to), at its discretion and
to the extent permitted by applicable law, over-allot and effect other
transactions with a view to supporting the market price of the Shares at a level
higher than that which might otherwise prevail in the open market. The
Stabilising Manager is not required to enter into such transactions and such
transactions may be effected on any stock market, over-the-counter market or
otherwise. Such stabilising measures, if commenced, may be discontinued at any
time and may only be taken during the period from the date of publication of the
Prospectus, until the date 30 days after the announcement of the Offer Price.
Save as required by law or regulation, neither the Stabilising Manager nor any
of its agents intends to disclose the extent of any over-allotments and/or
stabilisation transactions under the Offer.


Terms and Conditions

Investors purchasing Shares pursuant to the Offer are referred to Panmure
Gordon's terms and conditions of the Offer set out on the following pages.


TERMS AND CONDITIONS OF THE OFFER

Nothing in these terms and conditions shall be construed as an offer or a
solicitation of an offer to buy securities of the Company. Any such offer or
invitation will be made solely in or by reference to the Prospectus which is
expected to be published in due course and any acquisition of securities of the
Company should be made only on the basis of the information contained in the
Prospectus and any supplement or amendment thereto.


1.  Introduction

These terms and conditions apply to persons making an offer to purchase Shares
in the Company pursuant to the Offer as described in the Prospectus dated 13
December 2006.

By receiving this document and the Prospectus, each person to whom the terms and
conditions of the Offer apply, as described above (the 'Investor'), confirms his
agreement to Panmure Gordon (which may include Panmure Gordon or their nominee
(s), on behalf of itself and as agent of the Company) to purchase Shares under
the Offer. Each of the Investors shall, without limitation, become so bound if
Panmure Gordon confirms to such Investor (i) the Offer Price and (ii) its
allocation.


2.  Investors

2.1 If the Investor is a natural person, such Investor must not be under 
    the age of majority (18 years of age in the United Kingdom) on the date of
    such Investor's agreement to purchase Shares under the Offer;

2.2 Members of the public are not eligible to take part in the Offer. The Offer
    and the terms and conditions set out herein are directed only at persons 
    who are investment professionals within the definition set out in
    paragraph (5) of Article 19 or who fall within paragraph (2) of Article 49
    of the Financial Services and Markets Act 2000 (Financial Promotion) Order 
    2005, as amended. Any investment or investment activity to which the terms 
    and conditions set out herein relates is available only to such persons and
    will be engaged in only with such persons. These terms and conditions do not
    constitute an offer for sale of any securities in the Company in any 
    jurisdiction and any acquisition of Shares should only be made on the basis
    of information contained in the Prospectus.


3.  Terms of the offer

3.1 Application has been made to the London Stock Exchange for the Shares to be 
    admitted to trading on the main market for listed securities and it is 
    expected that such trading in the Shares will commence on 18 December 2006.
    The Shares will be sold pursuant to and be subject to the memorandum and
    articles of association of the Company, the principal terms of which are
    summarised in paragraph 3 of Part IX of the Prospectus.

3.2 The Investor's participation is conditional on the underwriting agreement 
    between the Company (and certain directors of the Company), the Selling 
    Shareholder, Dr Polonsky, Lazard, Panmure Gordon and Fox-Pitt, Kelton N.V. 
    ('Fox-Pitt, Kelton') dated 13 December 2006 (the 'Underwriting Agreement') 
    becoming unconditional in all respects and not having been terminated in 
    accordance with its terms. The Underwriting Agreement is conditional upon, 
    inter alia, Admission occurring by not later than 8.00 a.m. on 18 December 
    2006 (or such later time and/or date as the Company, the Selling 
    Shareholder, Lazard and Panmure Gordon may agree, not being later than 
    8.00 a.m.on 28 December 2006).

3.3 The Company, the Selling Shareholder, Panmure Gordon and Lazard may agree to
    extend the time for the satisfaction of any of the conditions of the 
    Underwriting Agreement (provided that such time may not be extended beyond
    31 December 2006). In the event that any such extension is agreed, Panmure 
    Gordon will inform the Investors at the earliest opportunity and all 
    subsequent dates referred to in the Prospectus will be adjusted 
    appropriately.

3.4 Subject to paragraph 8 below (Agreement to Acquire Shares), acceptance of 
    the offer incorporating the terms and conditions set out herein will 
    constitute a binding irrevocable commitment by the Investor, subject to the
    conditions set out below, to acquire and pay for the relevant number of 
    Shares which is not capable of termination or rescission by the Investor at
    any time or in any circumstances except fraud. All such obligations are 
    entered into by the Investor with Panmure Gordon in its capacity as agent 
    for the Selling Shareholder and are therefore directly enforceable by them.


4.  Underwriting Agreement

4.1 Panmure Gordon and Lazard have the right, inter alia, to terminate the 
    Underwriting Agreement (in their absolute discretion) if prior to Admission:

(a) any of the warranties contained in the Underwriting Agreementhas been 
    breached, which Panmure Gordon and Lazard reasonably consider in good faith 
    to be material within the context of the Offer, the underwriting of the
    Shares or Admission; or

(b) any statement contained in the Prospectus is, becomes or has been discovered
    to be untrue, incorrect or misleading in any respect, which Panmure Gordon 
    and Lazard reasonably consider to be material within the context of the 
    Offer, the underwriting of the Shares or Admission.

4.2 By agreeing to purchase Shares, each Investor agrees that any exercise by 
    Panmure Gordon or Lazard of any rights or discretions (including, without 
    limitation, any right to terminate the Underwriting Agreement or to waive or
    extend any condition in the Underwriting Agreement) shall be within Panmure 
    Gordon and Lazard's absolute discretion and that Panmure Gordon and Lazard 
    shall have no liability to the Investor whatsoever in connection with any
    decision to exercise or not to exercise any such right. Each Investor agrees
    that it has no rights against Panmure Gordon, Fox-Pitt, Kelton, Lazard, the
    Company or the Selling Shareholder or any of their respective directors or
    employees under the Underwriting Agreement pursuant to the Contracts (Rights
    of Third Parties) Act 1999. If the Underwriting Agreement does not become
    unconditional, or is terminated in accordance with its terms prior to 
    Admission, the Offer will not proceed and the Investor's rights and 
    obligations will cease and no claims will be capable of being made by the 
    Investor in respect of the Offer and any payments made by the Investor will 
    be returned as soon as possible thereafter without interest.


5.  Settlement

Settlement of transactions in Shares following the Admission will take place
within the CREST system. The ISIN number for the Shares is IM00B1H1XF89.
Admission is expected to take place and unconditional dealings in the Shares are
expected to commence on the London Stock Exchange at 8.00 a.m. on 18 December
2006. It is expected that the Shares allocated to Investors pursuant to the
Offer will be delivered in uncertificated form and settlement for uncertificated
shareholders will take place through CREST on 18 December 2006.


6.  Overseas Shareholders

6.1 No steps have been taken to enable any of the Shares to be acquired by 
    Investors outside the United Kingdom. By accepting any offer incorporating
    the terms and conditions contained herein, each Investor represents and 
    warrants to Panmure Gordon (for itself and as agent of the Company) that, 
    if the laws of any place outside the United Kingdom are applicable to the 
    Investor's agreement to purchase Shares and/or acceptance thereof, such 
    Investor:

(a) is entitled to acquire the Shares under the laws and regulatory requirements
    of all relevant jurisdictions which apply to it;

(b) has complied with all such laws and none of Panmure Gordon, Chamberlain Fund
    Services Limited (the 'Registrar'), the Company or the Selling Shareholder 
    will infringe any laws outside the United Kingdom as a result of such 
    Investor's agreement to purchase Shares and/or acceptance thereof or any 
    actions arising from such Investor's rights and obligations under the 
    Investor's agreement to purchase Shares and/or acceptance thereof;

(c) will pay any issue, transfer or other taxes due thereunder; and

(d) has not taken any action which will or may result in the Company, the 
    Selling Shareholder or Panmure Gordon acting in breach of any regulatory or 
    legal requirements of any territory in connection with the Offer or the
    Investor's acceptance of the terms and conditions herein.

6.2 The Shares have not been and will not be registered under the US Securities
    Act or under the securities law of any state of the United States, nor have
    they been qualified for sale under the securities legislation of any 
    province or territory of Australia, Canada or Japan and the relevant 
    exemptions are not being obtained from the securities commission or 
    regulatory body of any province of Canada and accordingly, the Shares may 
    not be offered, sold, taken up, delivered or transferred (directly or 
    indirectly) and will not qualify for sale within the United States, 
    Australia, Canada or Japan or to, or for the account or benefit of, any 
    national, citizen or resident or corporation in (or with a registered 
    address in) the United States, Australia, Canada or Japan.


7.  Tax

7.1 The Shares will be transferred free of all expenses and free of all stamp 
    duty and stamp duty reserve tax (SDRT) unless stamp duty or SDRT is 
    chargeable on the issue or transfer of Shares to the Investor under any of
    sections 67 and 93 (Depositary Receipts) or sections 70 or 96 (Clearance
    Services) of the Finance Act 1986. By accepting these terms and conditions
    the Investor confirms and warrants the Investor is not, and is not applying 
    as nominee or agent for, a person which is, or may be, mentioned in any of 
    sections 67, 70, 93 and 96 of the UK Finance Act 1986.


8.  Agreement to acquire Shares

8.1 This is conditional upon:

(a) Admission occurring on or prior to 8.00 a.m. on 18 December 2006 (or such 
    later date as Panmure Gordon, Lazard and the Company may agree (not being 
    later than 8.00 a.m. on 28 December 2006); and


(b) the confirmation by Panmure Gordon mentioned under paragraph 1 above 
    (the Confirmation);

whereupon each Investor agrees to become a member of the Company and agrees to
purchase such number of Shares as is set out or contained in the Confirmation at
the Offer Price, under the Offer in accordance with the terms and conditions set
out herein and in the Prospectus. To the fullest extent permitted by law and as
set out in paragraph 3.4 above, each Investor acknowledges and agrees that it
will not be entitled to exercise any remedy of rescission at any time. This does
not affect any other rights such Investor may have.


9.  Payment for Shares

9.1 Each Investor undertakes to pay the Offer Price for the Shares transferred 
    to such Investor in such manner as shall be directed by Panmure Gordon. 
    Subject to each Investor being able to give the representation and warranty
    set out in paragraph 7 above, such Investor will not be liable for stamp 
    duty and SDRT on the issue or transfer of the Shares.

9.2 In the event of any failure by any Investor to pay as so directed by Panmure
    Gordon, the relevant Investor shall be deemed hereby to have appointed 
    Panmure Gordon or any nominee of Panmure Gordon to use its reasonable 
    efforts to sell (in one or more transactions) any or all of the Shares in
    respect of which payment shall not have been made as directed by Panmure 
    Gordon and to have agreed to indemnify on demand Panmure Gordon in respect
    of any liability for stamp duty and/or SDRT arising in respect of any such
    sale or sales. A sale of all or any of such Shares shall not release the 
    relevant Investor from its obligation to make such payment for Shares to the
    extent that Panmure Gordon or its nominee has failed to sell such Shares at 
    a consideration which after deduction of the expenses of such sale and 
    payment of stamp duty and /or stamp duty reserve tax as aforementioned 
    exceeds the Offer Price per Share.


10.  Representations and Warranties

10.1 By agreeing to subscribe for or purchase Shares, each Investor and, in the
     case of paragraph 10.1(c) below, any person confirming his agreement to 
     purchase Shares on behalf of an Investor or authorising Panmure Gordon to
     notify an Investor's name to the Registrar, is deemed to represent and 
     warrant to Panmure Gordon, Fox-Pitt, Kelton, the Registrar, the Company and
     the Selling Shareholder that:

(a) in agreeing to subscribe for or purchase Shares, the Investor is relying on
    the Prospectus or any supplementary prospectus (as the case may be) and is
    not relying on any other information or representation relating to the 
    Offer, the Shares or the Company. Such Investor agrees that none of the 
    Company, the Registrar, Capita Registrars (Jersey) Limited, Lazard, Panmure
    Gordon, Fox-Pitt, Kelton, the Selling Shareholder or Dr Polonsky or any of 
    their respective officers or employees will have any liability for any such
    other information or representation;

(b) if the laws of any place outside the United Kingdom are applicable to the 
    Investor's agreement to purchase Shares and/or acceptance thereof, such 
    Investor has complied with all such laws and none of the parties mentioned
    under paragraph 10.1(a) above will infringe any laws outside the United 
    Kingdom as a result of such Investor's agreement to purchase Shares and/
    or acceptance thereof or any actions arising from such Investor's rights and
    obligations under the Investor's agreement to purchase Shares and/or 
    acceptance thereof or under the articles of association of the Company;

(c) in the case of a person who confirms to Panmure Gordon or Fox-Pitt, Kelton
    (as applicable) on behalf of an Investor an agreement to purchase Shares 
    and/or who authorises Panmure Gordon or Fox-Pitt, Kelton (as applicable) to
    notify the Investor's name to the Registrars as mentioned above, that person
    represents and warrants that he has authority to do so on behalf of the 
    Investor;

(d) it has the capacity and authority and is entitled to enter into and perform
    its obligations as a subscriber for or purchaser of Shares and will honour
    such obligations;

(e) it is not, and is not applying as nominee or agent for, a person which is, 
    or may be, mentioned in any of sections 67, 70, 93 and 96 of the UK Finance
    Act 1986 (depositary receipts and clearance services);

(f) it is a person within one of the following categories:

      (i)  persons whose ordinary activities involve them in acquiring, holding,
           managing or disposing of shares or debentures (as principal or agent)
           for the purposes of their business;

      (ii) persons who will acquire, hold, manage or dispose of the Shares 
           (as principal or agent) for the purposes of their businesses; or

      (iii)a restricted circle of persons whom the Company reasonably believes
           are sufficiently knowledgeable to understand the risks involved in 
           accepting the Offer;

(g) it irrevocably appoints any director of Panmure Gordon as its agent for the 
    purpose of executing and delivering to the Company and/or the Registrar any
    documents on its behalf necessary to enable it to be registered as the 
    holder of any of the Shares offered to it;

(h) it has obtained all necessary consents and authorities to enable it to give
    its commitment to subscribe for or purchase Shares and to perform its 
    obligations as set out herein;

(i) to the extent that an Investor is purchasing Shares on behalf of a third 
    party:

     (i)  such Investor has carried out applicable procedures to verify the 
          identity of such third party for the purposes of the Money Laundering
          Regulations 2003 (the 'Regulations');

     (ii) such Investor has complied fully with its obligations pursuant to the
          Regulations; and

     (iii)such Investor will provide Panmure Gordon on demand with any 
          information it might require for the purposes of verification under
          the Regulations; and

(j) if the Company or Panmure Gordon or any of their agents request any 
    information about a Investor's agreement to subscribe for or purchase 
    Shares, such Investor must promptly disclose it to them.


11.  Miscellaneous

11.1 The rights and remedies of Panmure Gordon, the Company, the Selling 
     Shareholder and the Registrar under these terms and conditions are in 
     addition to any rights and remedies which would otherwise be available to
     each of them and the exercise or partial exercise of one will not prevent
     the exercise of others.

11.2 All documents will be sent at the Investor's risk. They may be sent by post
     to such Investor at an address notified to Panmure Gordon.

11.3 Each Investor agrees to be bound by the articles of association of the 
     Company (as amended from time to time) once the Offer Shares which such
     Investor has agreed to purchase have been transferred to such Investor.

11.4 The contract to subscribe for or purchase Shares and the appointments and 
     authorities mentioned in this document will be governed by, and construed
     in accordance with, the laws of England. For the exclusive benefit of
     Panmure Gordon, Lazard, Fox-Pitt, Kelton, the Registrar, the Company and
     the Selling Shareholder, each Investor irrevocably submits to the exclusive
     jurisdiction of the English courts in respect of these matters. This does 
     not prevent an action being taken against an Investor in any other 
     jurisdiction.

11.5 In the case of a joint agreement to subscribe for or purchase Shares, 
     references to an 'Investor' in these terms and conditions are to each of
     such Investors and such Investors' liability is joint and several.

11.6 Terms defined in the foregoing pricing announcement have the same meaning
     in these terms and conditions, unless the context otherwise requires or 
     they are separately defined within these terms and conditions.







                      This information is provided by RNS
            The company news service from the London Stock Exchange